Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Venkatesh KumaresanDepartment of Molecular Microbiology and Immunology, South Texas Center for Emerging Infectious Diseases, San Antonio, TX, United States.
Susanta PahariHost Pathogen Interactions Program, Texas Biomedical Research Institute, San Antonio, TX, United States.
Chiung-Yu HungDepartment of Molecular Microbiology and Immunology, South Texas Center for Emerging Infectious Diseases, San Antonio, TX, United States.
Brian P HermannDepartment of Neuroscience, Developmental and Regenerative Biology, The University of Texas at San Antonio, San Antonio, TX, United States.
Larry S SchlesingerHost Pathogen Interactions Program, Texas Biomedical Research Institute, San Antonio, TX, United States.
J SeshuDepartment of Molecular Microbiology and Immunology, South Texas Center for Emerging Infectious Diseases, San Antonio, TX, United States.
Funding
Spatial analyses of marmoset germline developmentU01DA054170 · NIDA · UNIVERSITY OF TEXAS SAN ANTONIO · PI HERMANN, BRIAN PETER, HSIEH, JENNY · 2021 to 2025
$12.1M
RCMI Center for Interdiscplinary Health Research CIHRG12MD007591 · NIMHD · UNIVERSITY OF TEXAS SAN ANTONIO · PI PERRY, GEORGE · 2012 to 2016
$10.4M
Efficacy of novel reservoir-host targeted bait formulations against a tick-borne pathogenR01AI152233 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI SESHU, JANAKIRAM · 2021 to 2025
$1.9M
Pathogen-host interactions in Lyme disease interrogated at Single Cell LevelR21AI149263 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI SESHU, JANAKIRAM · 2021 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Role of dual specificity phosphatase 1 in influencing inflammatory pathways in macrophages modulated by · full record | Socratic